Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction.
Intraaortic balloon counterpulsation (IABP) has been shown to improve coronary artery potency and reduce the rates of recurrent myocardial ischemia and its sequelae in selected patients when used within 24 hours of acute myocardial infarction.
The economic implications of prophylactic IABP use are unknown.
We obtained hospital bills for 102 patients enrolled in the Randomized IABP Trial (56%) and converted charges to costs using each hospital's Medicare cost report.
In-hospital costs for patients who had 48 hours of IABP were compared with those of patients who did not.
The costs of angiographic and clinical complications were determined.
Small differences in clinical and angiographic characteristics existed between patients in the economic substudy and the overall population, but overall angiographic and clinical outcomes were comparable.
Costs for patients who had IABP versus control patients were similar : mean $22,357 ± $14,369 versus $19,211 ± $8,414, median (25th and 75th percentiles) $ 17,903 ($15,787, $22,147) versus S1 7,913 ($15,144, $21,433), p=0.45.
Hospital costs were higher with the development of recurrent ischemia : mean $23,125 ± $7,690 versus $20,416 ± $12,449, median $21,069 ($17,896, $26,885) versus $17,492 ($14,892, $20,998) p=0.02. (...)
Mots-clés Pascal : Infarctus, Myocarde, Aigu, Contrepulsation, Aorte, Sonde ballonnet, Perméabilité, Artère coronaire, Coût, Hospitalisation, Economie santé, Ischémie, Récidivant, Traitement, Prévention, Complication, Homme, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie, Réanimation cardiocirculatoire, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Infarct, Myocardium, Acute, Contrepulsation, Aorta, Cuffed tube, Permeability, Coronary artery, Costs, Hospitalization, Health economy, Ischemia, Recurrent, Treatment, Prevention, Complication, Human, Cardiovascular disease, Coronary heart disease, Myocardial disease, Intensive cardiocirculatory care, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0225813
Code Inist : 002B12A03. Création : 11/06/1997.